In the October 2021 issue of On Drug Delivery, Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how this acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies.

 

 

 

 

 

 

 

Read More

Read Our Recent Blogs

Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider

Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider Integrating the well-respected and trusted Agilis brand and team extends Kymanox’s capabilities in human factors (HF) by adding incredible talent, the ability to conduct HF stu...

Investment Reports Interview with Stephen M. Perry, CEO and Founder of Kymanox

Kymanox CEO and Founder, Stephen M. Perry was interviewed as part of the Investment Reports article, The New Era of Life Sciences 2023, published on 17MAR23, What were the circumstances that brought Kymanox to life and what does your present foo...

Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia

Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence   Friday, 03 February 2023 Morrisville, North Carolina, USA and Holzkirchen, Germany an...
See More Blogs